JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rizzo, C.
Right arrow Articles by de Franciscis, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rizzo, C.
Right arrow Articles by de Franciscis, V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 46, Issue of November 15, 1996 pp. 29497-29501
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Ligand Stimulation of a Ret Chimeric Receptor Carrying the Activating Mutation Responsible for the Multiple Endocrine Neoplasia Type 2B

(Received for publication, July 19, 1996, and in revised form, August 28, 1996)

Claudia Rizzo , Daniela Califano § , G. Luca Colucci-D'Amato , Gabriella De Vita , Amelia D'Alessio § , Nina A. Dathan , Alfredo Fusco par , Carmen Monaco § , Giovanni Santelli § , Giancarlo Vecchio , Massimo Santoro and Vittorio de Franciscis

From the Centro di Endocrinologia ed Oncologia Sperimentale del CNR, c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli "Federico II," via S. Pansini 5, 80131 Napoli, Italy, § Oncologia Sperimentale "E," Istituto Nazionale Tumori, Fondazione "G. Pascale," via M. Semmola, 80131 Napoli, Italy, and par  Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Reggio Calabria, via T. Campanella 5, 88100 Catanzaro, Italy

Inherited activating mutations of Ret, a receptor tyrosine kinase, predispose to multiple endocrine neoplasia (MEN) types 2A and 2B and familial medullary thyroid carcinoma. To investigate the effects induced by acute stimulation of Ret, we transfected both PC12 and NIH 3T3 cells with a molecular construct in which the ligand-binding domain of the epidermal growth factor receptor was fused to the catalytic domain of Ret. Acute stimulation of the chimeric receptor induced PC12 cells to express a neuronal-like phenotype. Moreover, we introduced the dominant mutation, responsible for the multiple endocrine neoplasia type 2B, in the catalytic domain of the Ret chimera. Expression of the mutant chimera, in the absence of ligand stimulation, induces the PC12 cells to acquire a flat morphology with short neuritic processes and transforms the NIH 3T3 cells. Stimulation of the mutant chimera with epidermal growth factor causes a drastic overgrowth of long neuritic processes, with the induction of the suc1-associated protein tyrosine phosphorylation in PC12 cells and higher transforming efficiency in NIH 3T3 cells. These data indicate that the gain-of-function MEN2B mutation does not abrogate ligand responsiveness of Ret and suggest that the presence of Ret ligand could play a role in the pathogenesis of the MEN2B syndrome.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Le Hir, L. G. Colucci-D’Amato, N. Charlet-Berguerand, P.-F. Plouin, X. Bertagna, Vittorio de Franciscis, and C. Thermes
High Levels of Tyrosine Phosphorylated Proto-Ret in Sporadic Pheochromocytomas
Cancer Res., March 1, 2000; 60(5): 1365 - 1370.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
S. H. Ong, G. R. Guy, Y. R. Hadari, S. Laks, N. Gotoh, J. Schlessinger, and I. Lax
FRS2 Proteins Recruit Intracellular Signaling Pathways by Binding to Diverse Targets on Fibroblast Growth Factor and Nerve Growth Factor Receptors
Mol. Cell. Biol., February 1, 2000; 20(3): 979 - 989.
[Abstract] [Full Text]


Home page
JCBHome page
J. Grimm, M. Sachs, S. Britsch, S. Di Cesare, T. Schwarz-Romond, K. Alitalo, and W. Birchmeier
Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation
J. Cell Biol., July 23, 2001; 154(2): 345 - 354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Gomez, C. Wellbrock, H. Gutbrod, N. Dimitrijevic, and M. Schartl
Ligand-independent Dimerization and Activation of the Oncogenic Xmrk Receptor by Two Mutations in the Extracellular Domain
J. Biol. Chem., January 26, 2001; 276(5): 3333 - 3340.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Besset, R. P. Scott, and C. F. Ibanez
Signaling Complexes and Protein-Protein Interactions Involved in the Activation of the Ras and Phosphatidylinositol 3-Kinase Pathways by the c-Ret Receptor Tyrosine Kinase
J. Biol. Chem., December 8, 2000; 275(50): 39159 - 39166.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Califano, C. Rizzo, A. D'Alessio, G. L. Colucci-D'Amato, G. Cali, P. C. Bartoli, G. Santelli, G. Vecchio, and V. de Franciscis
Signaling through Ras Is Essential for ret Oncogene-induced Cell Differentiation in PC12 Cells
J. Biol. Chem., June 16, 2000; 275(25): 19297 - 19305.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.